Abstract
The use of drug utilization management techniques such as formulary exclusions, prior authorizations, and step edits has risen sharply during the last decade, contributing to the growing burden on physicians and patients. Limited quantitative data exist, however, on physician perceptions of drug utilization management. A national survey was conducted between February 9 and March 30, 2021, targeting office-based physicians working in the United States to assess their perceptions on drug utilization management in their practice. Of the 742 physicians that participated in the study, over 80% reported deciding against prescribing certain treatments in anticipation of drug utilization management at least sometimes (>50% of the time). Despite utilization management having an impact on prescribing decisions, about half of physicians said that the utilization management policies they encounter rarely or never (0–25% of the time) align with clinical evidence.
Funder
Novartis Pharmaceuticals Corporation
Publisher
Public Library of Science (PLoS)
Reference23 articles.
1. Refocusing medication prior authorization on its intended purpose;JS Resneck;JAMA,2020
2. A Data Book: Healthcare Spending and the Medicare Program [Internet]. Medicare Payment Advisory Comission; 2019 [cited 2021 Jul 23]. Available from: http://www.medpac.gov/docs/default-source/data-book/jun19_databook_entirereport_sec.pdf?sfvrsn=0.
3. Has the era of slow growth for prescription drug spending ended?;M Aitken;Health Affairs.,2016
4. Skyrocketing Growth in PBM Formulary Exclusions Raises Concerns About Patient Access [Internet]. Xcenda; 2020 [cited 2021 Jul 23]. Available from: https://www.xcenda.com/insights/skyrocketing-growth-in-pbm-formulary-exclusions-raises-concerns-about-patient-access.
5. Specialty drug coverage varies across commercial health plans in the US.;JD Chambers;Health Affairs,2018
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献